Treatment of amyotrophic lateral sclerosis using placental stem cells
First Claim
1. A method of treating an individual having amyotrophic lateral sclerosis (ALS), comprising administering to the individual a therapeutically effective amount of placental stem cells, wherein the therapeutically effective amount is an amount sufficient to detectably reduce or ameliorate one or more symptoms of said ALS, and wherein administration occurs twice per month every one, two, or three months.
2 Assignments
0 Petitions
Accused Products
Abstract
Provided herein are methods of treatment of an individual having amyotrophic lateral sclerosis, comprising administering to the individual a therapeutically effective amount of placental stem cells, e.g., tissue culture surface-adherent placental stem cells (PDACs). In one aspect, provided herein is a method of treating amyotrophic lateral sclerosis (ALS) comprising administering to an individual having ALS a therapeutically effective amount of placental stem cells. In certain embodiments, “therapeutically effective” means an amount effective to reduce or ameliorate one or more symptoms of ALS.
-
Citations
20 Claims
- 1. A method of treating an individual having amyotrophic lateral sclerosis (ALS), comprising administering to the individual a therapeutically effective amount of placental stem cells, wherein the therapeutically effective amount is an amount sufficient to detectably reduce or ameliorate one or more symptoms of said ALS, and wherein administration occurs twice per month every one, two, or three months.
Specification